Searched for
WHY DIVIS LAB SHARES RISING
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its t...- Divi's Labs shares jump 8% to fresh 52-week high after Q2 profit soars 64% YoY. What brokerages say after bumper results?Divi’s Laboratories shares surged over 8% during Muhurat Trading, hitting a 52-week high after Q2 FY27 net profit jumped 64% to ₹1,127 cror...
- Oil Price Today (November 9): Crude oil falls below $100 again as Trump says fresh attacks ‘highly unlikely’. What are experts saying?Crude oil price: Prices came under further pressure after US President Donald Trump indicated that he was unlikely to authorise fresh attac...
- Oil falls on open as Trump says fresh Iran attacks 'unlikely'Oil prices fell at Monday's open after US President Donald Trump said he was highly unlikely to order fresh attacks on Iran as long as talk...
- Global Market Today: Asian stocks open mostly higher, Nvidia probe loomsBenchmark stock indexes rose in Japan and Australia after a gauge of US semiconductor shares jumped 4.2% on Friday as speculation about pos...
- Stocks in news: M&M, BHEL, Adani Enterprises, Wipro, Tata Steel, Siemens and Divi's LabsIndian equity markets ended marginally lower on Sunday, breaking a seven-session winning streak. The NSE Nifty 50 decreased by 44 points, c...
- Ahead of Market: 10 things that will decide stock market action on MondaySensex and Nifty ended lower during Muhurat Trading on November 8, snapping a six-session winning streak. Nifty slipped below 25,000 as inv...
- Divi's Labs Q2 Results: PAT surges 64% YoY to Rs 1,127 crore; revenue jumps 35%Divi's Laboratories has achieved a remarkable profit surge of 63.6% year-on-year for the September quarter of FY27, driven by a 35.4% incre...
- 12 midcap stocks deliver returns of up to 136% in FY27 so farMidcap stocks have outperformed the broader market in FY27, with 42 stocks gaining over 25%. We highlight 12 midcap stocks that have delive...
- Who is Shehzad Poonawalla? He beat Priyanka Chahar Choudhary to win Rise and Fall Season 2. Check the prize moneyRise and Fall Season 2 concluded with Shehzad Poonawalla taking the crown and Priyanka Chahar Choudhary finishing as the runner-up. The gra...
- Marico among 10 stocks hitting 52-week highs; rally up to 14% in a monthTen BSE 100 stocks, including Marico, Adani Ports, Divis Laboratories and ICICI Bank, hit fresh 52-week highs on Thursday as benchmark indi...
- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
- Dr Lal PathLabs posts higher quarterly profit on strong diagnostic test demandDr Lal PathLabs announced a 27% increase in its second-quarter profit, with net earnings rising to 1.92 billion rupees. The company experie...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities rallied nearly 2%, with Sensex gaining 1,225 points and Nifty rising 370 points. Falling crude prices, renewed FII buying, ...
- Indian Hotels Company among 6 stocks that hit 52-week highs and rallied up to 16% in a monthSix BSE 200 stocks, including Bosch, Coforge, Divi's Laboratories, Eternal, Indian Hotels and Zydus Lifesciences, touched fresh 52-week hig...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian stock markets surged nearly 2% on November 2, with Sensex gaining 1,233 points and Nifty rising 388 points. Falling crude oil prices...
- Ahead of Market: 10 things that will decide stock market action on MondaySensex and Nifty ended the week up about 0.5%, supported by resilient large-cap, IT and healthcare stocks. However, midcap and smallcap ind...
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- Laurus Labs shares climb 4% after Q2 profit zooms 126% YoYLaurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-ye...
- Pine Labs shares jump 7% as Q2 net profit soars 543% YoY to Rs 39 crorePine Labs shares rose sharply on Thursday after the fintech company reported a 543% year-on-year jump in Q2 FY27 net profit to Rs 38.6 cror...
Load More- Oil falls on open as Trump says fresh Iran attacks 'unlikely'
